戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 LA surface and exhibited a greater degree of crossreactivity.
2 amined for antigen specificity, isotype, and crossreactivity.
3 o distinguish true double sensitization from crossreactivity.
4 es it encounters is based on T cell receptor crossreactivity.
5 more, we conclude that MOR1(C)-ir represents crossreactivity.
6 eneous Tregs is not due to alloreactivity or crossreactivity.
7 of genotypes 2a, 3a, 4a, 5a, and 6a to study crossreactivity.
8 emonstrated their specificity and absence of crossreactivity.
9 y insensitive to ligand structure, to enable crossreactivity.
10  a "rigid adaptation" mechanism governs such crossreactivity.
11 al vaccine trials was shown to elicit M-type crossreactivity.
12 munogen carrying the 3D pattern would elicit crossreactivity against other M types carrying the 3D pa
13            This study evaluates the cellular crossreactivity among DR11, DR13, and DR8 molecules usin
14 d with distinct ligands revealed significant crossreactivity among MAIT TCRs both ex vivo and upon in
15               Confirmation of SARS-CoV-2/CCC crossreactivity and assessments of functional avidity we
16 a cooperative fashion such that specificity, crossreactivity and MHC restriction are inextricably lin
17 cognition properties, including specificity, crossreactivity and MHC restriction.
18 alysis of TCR antigen specificity, affinity, crossreactivity, and CD8 coreceptor dependence was perfo
19 rvation is supported by both direct binding, crossreactivity, and inhibition studies.
20 t work from our laboratory identified T cell crossreactivity between epitopes of OspA and lymphocyte
21 olecular-mimicry theory proposes that immune crossreactivity between microbial and self-antigen is th
22                                 Furthermore, crossreactivity between pork meat and dog dander extract
23 ow how binding by a self-reactive TCR favors crossreactivity between self and microbial antigens.
24  mechanisms, indicating that receptor-ligand crossreactivity can occur in the absence of molecular mi
25                                              Crossreactivity correlated with a shrinking, increasingl
26                                  True T cell crossreactivity, defined as the recognition by a single
27                       Here we show that such crossreactivity does not occur for tBRII, in that it doe
28 llenging because they usually show undesired crossreactivity for different Na(V) isoforms.
29  2 human Fabs (huFabs) (1A12, 1G3) with some crossreactivity for variants 1, 2, and 3.
30 ot retained on heparin agarose showed strong crossreactivity in immunoblot assays with anti-rat liver
31     There appeared to be a certain amount of crossreactivity in the binding of tetramers.
32        Structural analysis demonstrates this crossreactivity is due to structural mimicry of a bindin
33 e T cells, but the structural basis for such crossreactivity is not well understood.
34                           The basis for this crossreactivity is unknown but may be due in part to ant
35 terminally adjacent to the LBD increased the crossreactivity of monobodies to the apo-ER alpha-LBD, s
36 heir projections has been problematic due to crossreactivity of PYY antibodies with NPY.
37  report results of experiments examining the crossreactivity of TCRs recognizing the myelin basic pro
38 of these proteins which participate in their crossreactivity or in their direct interaction, represen
39 gnition either through T cell receptor (TCR) crossreactivity or independently from TCR recognition.
40 licheniformis 5A24, yet showed a distinctive crossreactivity pattern with other spores.
41 he precise molecular mechanism(s) behind the crossreactivity remain poorly understood.
42 functionally relevant indication of MAIT TCR crossreactivity, suggesting a potentially broader role o
43                                  The induced crossreactivity suggests that an anti-PfEMP1 vaccine may
44  determined and used to identify and exclude crossreactivity to noncognate peptides derived from the
45 e analyzed T-cell activation in the GALT and crossreactivity to the same antigen in the liver as well
46 s both sequence similarity and immunological crossreactivity to yeast Rrn3 and is capable of rescuing
47 gatively selected TCRs exhibited promiscuous crossreactivity toward multiple other major histocompati
48 cretion, and cytolytic ability, with limited crossreactivity toward nontargeted MHC alleles.
49                       The extent of MAIT TCR crossreactivity toward physiological, microbially unrela
50 eterologous CIDR1; however, a broad range of crossreactivity was detected in mice that were immunized
51 GlyRbeta (mAb-GlyRbeta) and does not exhibit crossreactivity with any of the GlyRalpha1-4 subunits.
52 ing a subtractive panning strategy to remove crossreactivity with B. licheniformis 5A24.
53 me selectivity of the TCR and its remarkable crossreactivity with different MHC-peptide complexes.
54                              T cell receptor crossreactivity with different peptide ligands and biase
55 es that in vitro demonstrate strong cellular crossreactivity with DR molecules expressed by the previ
56 s process through an unprecedented degree of crossreactivity with myelin-associated inhibitory ligand
57  6D2 bound tumor melanin and demonstrated no crossreactivity with normal melanized tissues in black m
58 bsorbed PYY antibody in the rat to avoid any crossreactivity with NPY.
59            Having established the absence of crossreactivity with related subunits, specific fluoresc
60 re we report the structural mechanism of TCR crossreactivity with two distinct peptides from human pa